PubGene gave a presentation about Coremine Oncology at a project meeting on 29 September, 2016. The aim of this project is to develop methods to utilize DNA sequencing in blood from cancer patients. Monitoring mutations previously detected in the primary tumour can help doctors to collect information about disease progression. PubGene’s role in this project is to develop workspace functionality within the Coremine Oncology framework to assist researchers, geneticists, and doctors in conducting clinical studies including cancer mutation sequencing. The users will be able to manage clinical studies, patients, samples and data files within the workspace and will also have mechanisms to comment and annotate clinical relevance and data quality status of specific mutations.